Perrigo (PRGO) Receivables - Net (2013 - 2026)
Perrigo's (PRGO) quarterly Receivables - Net came in at $697.1 million in Q1 2026, down 2.75% year-on-year from $716.8 million in Q1 2025, and up 13.76% on a QoQ basis from $612.8 million in Q4 2025.
Perrigo (PRGO) Receivables - Net (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Receivables - Net data on file, last reported at $697.1 million in Q1 2026.
- On a quarterly basis, Receivables - Net fell 2.75% year-over-year to $697.1 million in Q1 2026; TTM through Mar 2026 was $697.1 million, a 2.75% decrease from a year earlier, with the FY2025 full-year figure at $612.8 million, down 4.59% from the prior year.
- Receivables - Net for Q1 2026 stood at $697.1 million, up from $612.8 million in the prior quarter.
- Over the last five years, Receivables - Net for PRGO reached as high as $785.9 million in Q3 2024 and fell as low as $612.8 million in Q4 2025.
- Historically, Receivables - Net has averaged $711.1 million across 5 years, with a median of $716.8 million in 2025.
- Across the five-year window, Receivables - Net climbed 20.98% in 2022 and slipped 18.0% in 2025, its largest moves.
- Year by year, Receivables - Net stood at $697.1 million in 2022, then advanced by 6.1% to $739.6 million in 2023, then retreated by 13.16% to $642.3 million in 2024, then dropped by 4.59% to $612.8 million in 2025, then climbed by 13.76% to $697.1 million in 2026.
- Per Business Quant data, the three most recent Receivables - Net figures were $697.1 million in Q1 2026, $612.8 million in Q4 2025, and $644.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 697.10 Mn |
| Mar 28, 2026 | 697.10 Mn |
| Dec 31, 2025 | 612.80 Mn |
| Dec 31, 2025 | 612.80 Mn |
| Sep 27, 2025 | 644.40 Mn |
| Sep 27, 2025 | 644.40 Mn |
| Jun 28, 2025 | 678.20 Mn |
| Jun 28, 2025 | 678.20 Mn |
| Mar 29, 2025 | 716.80 Mn |
| Mar 29, 2025 | 716.80 Mn |
| Dec 31, 2024 | 642.30 Mn |
| Dec 31, 2024 | 642.30 Mn |
| Sep 28, 2024 | 785.90 Mn |
| Sep 28, 2024 | 785.90 Mn |
| Jun 29, 2024 | 726.00 Mn |
| Jun 29, 2024 | 726.00 Mn |
| Mar 30, 2024 | 780.00 Mn |
| Mar 30, 2024 | 780.00 Mn |
| Dec 31, 2023 | 739.60 Mn |
| Dec 31, 2023 | 739.60 Mn |